Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CLEVER LEAVES HOLDINGS INC.

(CLVR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Clever Leaves : Exports First Commercial Cannabis Flower Shipment to US

10/06/2021 | 10:24am EST


ę MT Newswires 2021
All news about CLEVER LEAVES HOLDINGS INC.
11/10Clever Leaves Reports Third Quarter 2021 Results - Form 8-K
PU
11/10CLEVER LEAVES HOLDINGS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIO..
AQ
11/10Earnings Flash (CLVR) CLEVER LEAVES Reports Q3 Revenue $4M, vs. Street Est of $4.56M
MT
11/10Clever Leaves Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Mon..
CI
11/10Clever Leaves Reports Third Quarter 2021 Results
AQ
11/10Clever Leaves Holdings Inc. Revises Revenue Guidance for the Year 2021
CI
10/19CLEVER LEAVES : Launches Partnership to Supply Cannabinoid Formulations in Colombia
MT
10/19CLEVER LEAVES : Announces Partnership with Colombian-based Pharmalab PHL Laboratories to P..
AQ
10/19Clever Leaves Holdings Inc Announces Partnership with Colombian-based Pharmalab PHL Lab..
CI
10/06CLEVER LEAVES : Exports First Commercial Cannabis Flower Shipment to US
MT
More news
Analyst Recommendations on CLEVER LEAVES HOLDINGS INC.
More recommendations
Financials (USD)
Sales 2021 15,1 M - -
Net income 2021 -32,6 M - -
Net Debt 2021 - - -
P/E ratio 2021 -4,02x
Yield 2021 -
Capitalization 134 M 134 M -
Capi. / Sales 2021 8,83x
Capi. / Sales 2022 5,34x
Nbr of Employees 477
Free-Float 74,8%
Chart CLEVER LEAVES HOLDINGS INC.
Duration : Period :
Clever Leaves Holdings Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CLEVER LEAVES HOLDINGS INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 4,96 $
Average target price 9,00 $
Spread / Average Target 81,5%
EPS Revisions
Managers and Directors
Kyle Detwiler Chief Executive Officer & Director
AndrÚs Fajardo President & Director
Henry R Hague Chief Financial Officer
David M. Kastin Secretary & General Counsel
Gary M. Julien Independent Director
Sector and Competitors
1st jan.Capi. (M$)
CLEVER LEAVES HOLDINGS INC.-45.17%131
BY-HEALTH CO., LTD.-2.53%6 362
BALCHEM CORPORATION40.81%5 254
HERBALIFE NUTRITION LTD.-19.29%3 961
THE SIMPLY GOOD FOODS COMPANY20.44%3 620
MEDIFAST, INC.7.15%2 435